Daewoong Pharmaceutical Company Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Daewoong Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
Hanmi Pharmaceutical., Company Limited
sales of 916.59 billion Korean Won [US$802.01 million]
of which 76%
Kwang Dong Pharmaceutical Company Limited
(1.14 trillion Korean Won [US$998.87 million]
of which 40%
was MRO), and
Daewoong Company Limited
(1.12 trillion Korean Won [US$983.57 million]
of which 113%
was Medicinal Manufacturing & Selling).
During the year ended December of 2017, sales at
Daewoong Pharmaceutical Company Limited were 960.31 billion Korean Won (US$840.27 million).
increase of 8.6%
versus 2016, when the company's sales were 883.92 billion Korean Won.
This was the fifth consecutive year of sales increases at Daewoong Pharmaceutical Company Limited
(and since 2012, sales have increased a total of 44%).
Sales of Others saw an increase
that was more than double the company's growth rate: sales were up
47.6% in 2017, from
476.94 million Korean Won to 704.17 million Korean Won.
Daewoong Pharmaceutical Company Limited also saw significant increases in sales in
Prevention Diseases (up 39.6% to 6.09 billion Korean Won)